2020
DOI: 10.1007/s12011-020-02209-5
|View full text |Cite
|
Sign up to set email alerts
|

The Effects of Magnesium Supplementation on Lipid Profile Among Type 2 Diabetes Patients: a Systematic Review and Meta-analysis of Randomized Controlled Trials

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
10
2

Year Published

2021
2021
2024
2024

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 19 publications
(16 citation statements)
references
References 46 publications
0
10
2
Order By: Relevance
“…One earlier meta-analysis study suggested no significant effects of Mg supplementation on the lipid profiles among individuals with or without diabetes (43). However, one recent meta-analysis study concluded that Mg supplementation could significantly lower the LDL level in patients with diabetes (44). These different findings may be accounted for the blood Mg levels of the population enrolled in our study being higher than those of patients with diabetes, chronic kidney disease, or hypomagnesemia (3,42,44).…”
Section: Discussioncontrasting
confidence: 59%
See 1 more Smart Citation
“…One earlier meta-analysis study suggested no significant effects of Mg supplementation on the lipid profiles among individuals with or without diabetes (43). However, one recent meta-analysis study concluded that Mg supplementation could significantly lower the LDL level in patients with diabetes (44). These different findings may be accounted for the blood Mg levels of the population enrolled in our study being higher than those of patients with diabetes, chronic kidney disease, or hypomagnesemia (3,42,44).…”
Section: Discussioncontrasting
confidence: 59%
“…However, one recent meta-analysis study concluded that Mg supplementation could significantly lower the LDL level in patients with diabetes (44). These different findings may be accounted for the blood Mg levels of the population enrolled in our study being higher than those of patients with diabetes, chronic kidney disease, or hypomagnesemia (3,42,44). It indicates that overindulging or unnecessary Mg supplementation may harm lipid profiles.…”
Section: Discussioncontrasting
confidence: 56%
“…In the human body, magnesium is a cofactor in several enzyme systems such as Na + /K + -ATPase, hexokinase, creatine kinase, protein kinase. Also, magnesium plays a role in signal transduction, protein synthesis, neuromuscular conduction,, muscle and nerve transmission, blood glucose control, and blood pressure regulation [ 37 38 39 ]. Abnormal magnesium homeostasis can lead to metabolic disorders, such as diabetes [ 40 ].…”
Section: Discussionmentioning
confidence: 99%
“…Mg is an important factor in CKD mineral bone disorders (CKD-MBD) as it can suppress parathyroid hormone (PTH) secretion, activate the calcium-sensing receptor, promote osteoblast activity, and reduce intestinal phosphate absorption [ 40 , 70 , 71 ]. Although low Mg levels stimulate PTH secretion, Mg is also required for the production and release of PTH and therefore severe hypomagnesemia can lead to clinical hypocalcemia via hypoparathyroidism [ 72 , 95 ]. For these reasons, administration of Mg is of interest for its potential to modify CKD-MBD.…”
Section: Magnesium Administration To Improve Healthmentioning
confidence: 99%